Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.53 |
| ▸ | CA1 | P00915 | 10/20 | 0.48 |
| ▸ | CA12 | O43570 | 6/20 | 0.43 |
| ▸ | CA9 | Q16790 | 6/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18509335 | 0.80 | HDAC4 (0.56) | CA2CA1CA12CA9CA4 | |
| SCHEMBL23364593 | 0.78 | CA2 (0.61) | CA2CA1CA12CA9CA4 | |
| SCHEMBL84614 | 0.78 | CA2 (0.61) | CA2CA1CA12CA9CA4 | |
| SCHEMBL17760485 | 0.77 | CA2 (0.47) | CA2CA1CA12CA9CA4 | |
| SCHEMBL4631093 | 0.76 | CA2 (0.59) | CA2CA1CA12CA9CA4 | |
| SCHEMBL12052154 | 0.76 | CA2 (0.59) | CA2CA1CA12CA9CA4 | |
| SCHEMBL8249478 | 0.76 | CA2 (0.59) | CA2CA1CA12CA9CA4 | |
| SCHEMBL7137010 | 0.75 | CA2 (0.57) | CA2CA1CA12CA9CA4 | |
| Hydrochloric Acid SCHEMBL31365115 | 0.75 | CA2 (0.57) | CA2CA1CA12CA9CA4 | |
| Hydrochloric Acid SCHEMBL7142051 | 0.75 | CA2 (0.57) | CA2CA1CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212641-A1 | THIAZOLES AS MODULATORS OF RORyt | Janssen Pharmaceutica NV (BE) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016069976-A1 | THIAZOLES AS MODULATORS OF RORyt | JANSSEN PHARMACEUTICA NV (BE) | 2016-05-06 | — | — | WO | disclosed |